Legend Biotech Corporation
LEGN | NASDAQ
$18.66
+$0.13 (+0.70%)
Sep 22, 2026, 12:43 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -13.59 | -33.55 | -20.47 | -17.77 | -17.01 | -10.96 |
PEG Ratio | -0.21 | 0.50 | -4.42 | -6.95 | -2.57 | -0.07 |
PS Ratio | 3.89 | 9.49 | 37.16 | 67.86 | 95.39 | 44.36 |
PB Ratio | 4 | 5.72 | 8.47 | 10.67 | 8.57 | 5.57 |
P/FCF Ratio | -23.85 | -37.63 | -25.47 | -35.51 | -26.92 | -13.14 |
P/OCF Ratio | -39.89 | -41.31 | -26.94 | -39.44 | -33.08 | -14.92 |
OCF/S Ratio | -9.76 | -22.96 | -137.92 | -172.03 | -288.36 | -297.34 |
Debt / Equity Ratio | 0.41 | 0.34 | 0.26 | 0.38 | 0.16 | 0.01 |
Quick Ratio | 1.91 | 4.54 | 6.83 | 3.66 | 4.14 | 5.12 |
Current Ratio | 1.96 | 4.62 | 6.92 | 3.69 | 4.14 | 5.14 |
Asset Turnover | 0.59 | 0.38 | 0.15 | 0.09 | 0.06 | 0.10 |
Interest Coverage | -6.38 | -14.03 | -20.17 | -42.20 | -435.87 | n/a |
Return on Equity | -29.62% | -17.01% | -41.41% | -59.97% | -52.69% | -44.56% |
Return on Assets | -17.12% | -10.60% | -28.03% | -33.54% | -36.05% | -36.89% |
Return on Invested Capital | -9.59% | -21.70% | -26.78% | -43.95% | -43.63% | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 60.34% | 62.60% | 49.42% | 44.14% | 100% | 100% |
Net Profit Margin | -28.85% | -28.22% | -181.75% | -381.48% | -586.38% | -355.16% |
Pretax Profit Margin | -27.47% | -25.21% | -182.41% | -380.94% | -591.63% | -411.05% |
Operating Profit Margin | -13.27% | -48.35% | -154.13% | -389.40% | -569.97% | n/a |
FCF Margin | -16.33% | -25.21% | -145.89% | -191.07% | -354.33% | -337.72% |
EBITDA Margin | -22.58% | -18.04% | -167.59% | -356% | -570.10% | -397.54% |
Add to Watchlist
Select watchlists to add or remove LEGN